Form 4: Structure Therapeutics Executive Receives Stock Grant
Insider Transaction (Form 4)
John Joseph Berrios, Chief Commercial Officer of Structure Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
Summary
- Grant/award: acquired 140,766 Ordinary Shares on August 6, 2026; holds 140,766 after (Direct).
- Grant/award: acquired 174,612 Share option (right to buy) on August 6, 2026; holds 174,612 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John Joseph Berrios — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Grant/award | Ordinary Shares | 140,766 | — | — | 140,766 |
| 2026-08-06 | Grant/award | Share option (right to buy) | 174,612 | — | — | 174,612 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Grant/award (140,766 shares) |
| 2026-08-06 | Grant/award (174,612 shares) |
Keywords
insider transaction, Form 4, GPCR, Structure Therapeutics Inc., neutral, John Joseph Berrios
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.